OKYO Pharma OKYO Cash Flow Statement (2021-2026)

NASDAQ OKYO
$1.36 -0.01 (-0.73%)
At close: Sep 29, 2026 · 4:00 PM EDT
Reported Financials

OKYO Pharma Quarterly Cash Flow Statement

Periods 8 quarters
Latest Mar 2026

OKYO Pharma reported cash from operations of -$4.12M and free cash flow of $4867.88M for the quarter ended Mar 2026. This cash flow statement covers 8 quarters of results from Mar 2021 through Mar 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Mar2021 Mar2022 Mar2023 Sep2023 Mar2024 Mar2025 Dec2025 Mar2026
Operating Activities
Depreciation and Depletion -0.00M2,563.00M-743.00M
Share-based Compensation 0.19M0.87M
Non-cash Items 0.04M-0.04M
Cash from Operations -0.28M-4.12M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Depreciation & Amortization -0.00M2,563.00M-743.00M
Change in Working Capital
Change in Receivables 0.09M0.10M
Change in Account Payables 1.86M-0.85M
Investing Activities
Capital Expenditures -4872.00M
Cash from Investing Activities 1,201.99M
Financing Activities
Change in Capital Stock
Shares Issued 0.08M0.06M0.03M0.01M0.35M0.35M
Net Equity Issued and Repurchased -2.61M23.32M
Misc.
Cash from Financing Activities -1.66M22.37M
Exchange Rate Effect 0.02M0.06M
Change in Cash 12.24M
Free Cash Flow -0.28M4,867.88M
Net Cash Flow -1.94M1,220.24M

OKYO Pharma Cash Flow Statement API

Pull OKYO Pharma's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=OKYO&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY